Trump announces lower drug price deals with 9 pharmaceutical companies

Source: ABC News | Published: December 19, 2025, 10:13 pm | Read Original

Neutral 0.0

U.S. President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the U.S. Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis and Sanofi will ...

Read Source Login to use Pulse AI

Pulse AI Analysis

Pulse analysis not available yet. Click "Get Pulse" above.

This analysis was generated using Pulse AI, Glideslope's proprietary AI engine designed to interpret market sentiment and economic signals. Results are for informational purposes only and do not constitute financial advice.

More Like This

Market & Industry Analysis Straight to Your Inbox

Glideslope AI

Trump announces lower drug price deals with 9 pharmaceutical companies

U.S. President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the U.S. Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis and Sanofi will ...

ABC News • Dec 19, 2025 • Found on Glideslope.ai

Post hash: i6crh91 • glideslope.ai/post/i6crh91

Sentiment

Neutral • Score: 0.0

-100 (Bearish) +100 (Bullish)

Fraywire Market Portal, Breaking Metrics Newsletter, and Glideslope AI are designed for informational purposes only. The content provided across these platforms—including, but not limited to, stock and crypto watchlists, price tracking, trade tracking, sentiment analysis, and news articles—should not be construed as financial advice or research reports. Users are encouraged to conduct their own research and consult with qualified financial professionals before making any investment decisions. While we strive to ensure the accuracy, completeness, and reliability of the information provided, Fraywire, Breaking Metrics, and Glideslope AI make no guarantees or warranties regarding the content's validity. By using these platforms, you acknowledge and agree that you are solely responsible for your own investment decisions and actions. Fraywire, Breaking Metrics, and Glideslope AI shall not be held liable for any losses or damages resulting from the use of the information provided.

Get Connected

Fraywire & Glideslope AI are Breaking Metrics productions.
Contact the developer for advertising opportunities, questions, and more at roy@rmahd.com

○ Subscribe
○ Fraywire+
○ Glideslope AI
○ Blog
○ RMAHD
○ Merch!

Pulse AI Analysis

Related Insights

More Like This

How Trump's cannabis reclassification move could impact research

What's next for TikTok after ByteDance signs deal to avoid U.S. ban

Teen Gangsters Plead Guilty To Serving As Hitmen For Deadly Drug Cartel

Building venture-backable companies in heavily regulated spaces

Elon Musk’s 2018 Tesla Pay Deal Is Restored by Delaware Supreme Court

Elon Musk wins appeal to restore $56B Tesla pay deal that was called ‘unfathomable’

Market & Industry Analysis Straight to Your Inbox

My Notes